BAYER SAYS INVESTORS WITH 91.69% OF EQUITY CAPITAL REPRESENTED AT THE AGM VOTED IN FAVOUR OF CEO AND TOP MANAGEMENT TEAM
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.99 EUR | -1.15% | +1.12% | -13.74% |
May. 15 | Bayer Starts Phase I Study with Novel Targeted Radionuclide Therapy 225Ac-Psma-Trillium in Advanced Metastatic Prostate Cancer | CI |
May. 15 | BAYER AG : Barclays remains Neutral | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.75% | 31.31B | |
+35.01% | 709B | |
+30.64% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.08% | 239B | |
+9.28% | 211B | |
-3.35% | 203B | |
+10.77% | 171B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer Says Investors With 91.69% Of Equity Capital Represented A…